Literature DB >> 6233348

Patient attrition in a comparative outcome study of depression. A follow-up report.

A D Simons, J L Levine, P J Lustman, G E Murphy.   

Abstract

Eighty-seven moderately to severely depressed psychiatric outpatients were randomly assigned to 12 weeks of cognitive therapy (n = 24), pharmacotherapy (n = 24), cognitive therapy plus pharmacotherapy (n = 22) or cognitive therapy plus active placebo (n = 17). Seventy patients completed the treatment protocol; 17 dropped out before the end of the treatment period. Completers and dropouts did not differ at pretreatment on demographic variables, measures of depression, cognitive functioning or social adjustment. Sixteen of the 17 patients who dropped out were followed up and interviewed to assess their clinical status and reasons for discontinuing treatment. Neither group remained depressed at follow-up. Practical matters and issues related to the type of treatment received seemed to contribute most to patients' decision to drop out. Patients assigned to the combination therapies were more likely to complete the research protocol than those assigned to single treatment modalities. These findings are discussed in terms of their implications for clinical practice and outcome research.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233348     DOI: 10.1016/0165-0327(84)90021-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Predictors and Patterns of Psychiatric Treatment Dropout During Pregnancy Among Low-Income Women.

Authors:  Sara L Kornfield; Christina D Kang-Yi; David S Mandell; C Neill Epperson
Journal:  Matern Child Health J       Date:  2018-02

2.  Dropout from outpatient mental health care: results from the Israel National Health Survey.

Authors:  Yaacov Lerner; Daphna Levinson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-06-12       Impact factor: 4.328

3.  Predictors of treatment utilization in major depression.

Authors:  Dana M Alonzo; Jill M Harkavy-Friedman; Barbara Stanley; Ainsley Burke; J John Mann; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2011

4.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Cancer patients' perspectives on discontinuing depression treatment: the "drop out" phenomenon.

Authors:  Anjanette A Wells; Lawrence A Palinkas; Xuxu Qiu; Kathleen Ell
Journal:  Patient Prefer Adherence       Date:  2011-09-26       Impact factor: 2.711

Review 6.  The effects of cognitive therapy versus 'treatment as usual' in patients with major depressive disorder.

Authors:  Janus Christian Jakobsen; Jane Lindschou Hansen; Ole Jakob Storebø; Erik Simonsen; Christian Gluud
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

7.  The effects of cognitive therapy versus 'no intervention' for major depressive disorder.

Authors:  Janus Christian Jakobsen; Jane Lindschou Hansen; Ole Jakob Storebø; Erik Simonsen; Christian Gluud
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  Prediction of Dropout in a Randomized Controlled Trial of Adjunctive Light Treatment in Patients with Non-Seasonal Depression and Evening Chronotype.

Authors:  Joey W Y Chan; Shirley Xin Li; Steven Wai Ho Chau; Ngan Yin Chan; Jihui Zhang; Yun Kwok Wing
Journal:  Clocks Sleep       Date:  2022-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.